OT
Oruka Therapeutics, Inc.
🇺🇸XNAS.ORKAUnited StatesHealthcare
$95.08USDup +2.89 (+3.13%)OpenDelayed5:45 PM
Price$95.08+2.89 (+3.13%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US6876041087
- CUSIP
- 687604108
Company
- Employees
- 68
- Headquarters
- Menlo Park, United States
- Website
- https://orukatx.com
- CEO
- Dr. Lawrence Otto Klein Ph.D.
Market
- Shares outstanding
- 66.2M
- Market cap
- $6.3B
Highlights
- Market cap
- $6.04B
- EPS LTM
- -$2.11
- P/E LTM
- -44.13
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $00%unchanged year on year
- Net income
- -$132.89M-23.51%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$101.15M-3.3%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.